Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.

Autor: Chang A; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA., Koff JL; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Lai L; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Emory National Primate Research Center, Atlanta, GA., Orellana-Noia VM; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Surati M; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Leal AMK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Ellis ML; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Wali B; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Moreno A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Linderman SL; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA., O'Leary CB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Allen PB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Churnetski MC; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Dhodapkar MV; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Suthar MS; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Ahmed R; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2023 Jun 13; Vol. 7 (11), pp. 2459-2462.
DOI: 10.1182/bloodadvances.2022009475
Databáze: MEDLINE